Recent FDA Indications in Endometrial Cancers

Brian Slomovitz

Year in Review 2024 - Endometrial Cancer

Mansoor Raza Mirza

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Endometrial Cancer: The Current Treatment Landscape

Hope Cottrill

IGCS 2024 Summary and Highlights: Key Trial Insights on Endometrial …

UCLA Health

D. Chase

ESMO 2024 Insights: Pembro or Placebo in Combination With Adjuvant C…

2024 ESMO Annual Meeting Insights Hub

B. Slomovitz

A Wolf in Sheep's Clothing: When a Fibroid is Not a Fibroid

60th Annual Update: Obstetrics and Gynecology 2024

M. Ajao

Advancing Precision: Innovations in Minimally Invasive Gynecologic S…

Jessica Opoku-Anane

The Changing Field of Endometrial Cancer Treatment

GRACE

M. Raza Mirza

SGO 2024 Endometrial Cancer Highlights

Insights from 2024 SGO Annual Meeting

P. Binder

Cancer Screening Molecular Tools

Fengting Yan

Phase III Trials of Adjuvant Radiotherapy and Chemotherapy in Endome…

GRACE

M. Raza Mirza

Durvalumab/C/T as 1L Treatment for dMMR Advanced Endometrial Cancer:…

Dana Chase

Precision Oncology in the Management of Endometrial Cancer

Miami Cancer Institute Precision Oncology Symposium

J. Diaz, B. Slomovitz

Endometrial Cancer: Risk Factors, Prognostic Challenges, and Staging…

Hope Cottrill

Molecular Subclassifications of Endometrial Cancer and Corresponding…

University of Miami Sylvester Comprehensive Cancer Center

A. Sinno

SGO 2024 Summary: "Key Updates in Endometrial Cancer"

Insights from 2024 SGO Annual Meeting

M. Raza Mirza

Classification, Diagnosis and Treatment of Endometrial Cancer in 2024

Yale Cancer Center

P. Dottino

SGO 2024 Insights: "GOG-0258 - OS by Molecular Classification With a…

Insights from 2024 SGO Annual Meeting

A. Clements